Histone deacetylase

From Proteopedia

proteopedia linkproteopedia link

Revision as of 08:45, 23 March 2016 (edit) Michal Harel (Talk | contribs) ← Previous diff		Revision as of 08:57, 23 March 2016 (edit) (undo) Michal Harel (Talk | contribs) Next diff →
Line 93:		Line 93:
	*Sir2		*Sir2
-	**[[2hjh]] – yHDAC Sir2 - yeast<br />	+	**[[2hjh]] – yHDAC Sir2 + pseudosubstrate + nicotinamide - yeast<br />
-	**[[4iao]] – yHDAC Sir2 + Sir4<br />	+	**[[4iao]] – yHDAC Sir2 + Sir4 + adenosine diphosphoribose<br />
	}}		}}
	== References ==		== References ==
	<references/>		<references/>
	[[Category:Topic Page]]		[[Category:Topic Page]]

---

Revision as of 08:57, 23 March 2016

Template:STRUCTURE 3ewf

Contents 1 Function 2 Relevance 3 3D Structures of histone deacetylase 4 References

Function

Histone deacetylase (HDAC) catalyzes the removal of acetyl group from ε-N-acetyl lysine in histones^[1]. HDAC contains Zn. DNA expression is regulated by acetylation and de-acetylation. HDAC are classified according to their domain organization to 4 classes. SAHA is a common inhibitor of HDAC. For additional details see

• Understanding of the Recruitment of HDACs by MEF2, Based on Their Structure
  
• Transcription and RNA Processing.

Relevance

HDAC inhibitors are used in cancer therapy^[2].

3D Structures of histone deacetylase

Updated on 23-March-2016

References

1. ↑ Joshi P, Greco TM, Guise AJ, Luo Y, Yu F, Nesvizhskii AI, Cristea IM. The functional interactome landscape of the human histone deacetylase family. Mol Syst Biol. 2013;9:672. doi: 10.1038/msb.2013.26. PMID:23752268 doi:http://dx.doi.org/10.1038/msb.2013.26
2. ↑ Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer. 2001 Dec;1(3):194-202. PMID:11902574 doi:http://dx.doi.org/10.1038/35106079